Boehringer Ingelheim acquires GST to expand stem cell capabilities
By Nikita Chaurasia  Date: 2020-07-29

Boehringer Ingelheim acquires GST to expand stem cell capabilities

Boehringer Ingelheim, a leader in pharmaceutical products, has recently made it to the headlines by acquiring Belgium-based veterinary biotech firm, Global Stem cell Technology (GST).

According to reliable sources, the collaboration with GST will allow Boehringer to expand its development pipeline, while parallelly focusing on setting higher standards of animal healthcare. However, the financial details of the deal were not disclosed.

The two companies had initially partnered in the year 2018 and had launched a stem cell product, Arti-Cell® Forte in 2019.  Arti-Cell® Forte is apparently the first stem cell product which was granted marketing authorization by the European commission in the veterinary domain.

Boehringer Ingelheim Animal Health’s Head of Global Strategic Marketing Jean-Luc Michel, was reported stating that the company had finally decided to acquire GST after two years of partnership which will help in expanding Boehringer Ingelheim’s portfolio. He added that GST’s expertise in stem cell production will allow Boehringer to  deliver advanced and innovative solutions to their clients.

Jan Spaas CEO of GST mentioned that that Boehringer Ingelheim’s mission to lead a new wave of development and innovation in the veterinary industry complies with GST vision. He further claimed that GST will operate as a new research and development division Boehringer’s banner.

For those uninitiated, Boehringer Ingelheim Animal Health is one of the largest animal health businesses in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 countries.

On the other hand, Global Stem cell Technology (GST) is a biotech company with primary focus on R&D activities and manufacture of veterinary stem cell-based products.

In other news, Boehringer Ingelheim had recently teamed up with Biognosys to enhance next-gen proteomics applications for drug development and discovery.

Source credits: https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-acquires-global-stem-cell-technology

https://www.news-medical.net/news/20200724/Boehringer-Ingelheim-and-Biognosys-join-forces-on-applying-quantitative-proteomics-tools-in-drug-discovery.aspx

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Generac, Baker partner to offer solar & storage installations in U.S.
Generac, Baker partner to offer solar & storage installations in U.S.
By Nikita Chaurasia

Generac Holdings Inc., a Wisconsin-based leading backup power generation developer, has reportedly entered a joint venture agreement with a solar electric solutions provider Baker Electric Home Energy. Sources close to the matter stated that the two ...

Education analytics platform HelioCampus acquires ABC Insights
Education analytics platform HelioCampus acquires ABC Insights
By Nikita Chaurasia

HelioCampus, a leading higher education analytics platform that offers universities and colleges the decision-support assistance they require to work more sustainably and strategically, has reportedly announced that it acquired ABC Insights, a renown...

Deutsche Telekom, OVHcloud partner to offer cloud services in Europe
Deutsche Telekom, OVHcloud partner to offer cloud services in Europe
By Nikita Chaurasia

Deutsche Telekom AG, the German telecommunication services provider, has reportedly teamed up with a France-based company OVHcloud. Sources with knowledge of the matter stated that the two companies intend to provide alternative cloud computing servi...

Graphics firm NVIDIA to acquire Arm from SoftBank for $40 billion
Graphics firm NVIDIA to acquire Arm from SoftBank for $40 billion
By Nikita Chaurasia

NVIDIA, a leading American multinational technology firm, and SoftBank, a renowned Japanese conglomerate, have reportedly announced that NVIDIA would acquire Arm Limited from SoftBank Group for a total amount of $40 billion. The agreement would be im...

QHR Health buys Resolution to reinforce its community health services
QHR Health buys Resolution to reinforce its community health services
By Nikita Chaurasia

In a recent turn of events, U.S.-based technological healthcare company QHR Health has reportedly announced the acquisition of revenue cycle services provider, Resolution, in order to strengthen its community healthcare services across the United Sta...